The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 10, 2015
Filed:
Nov. 20, 2014
Sumitomo Dainippon Pharma Co., Ltd., Osaka-shi, JP;
International Institute of Cancer Immunology, Inc., Suita-shi, JP;
Chiang Jia Li, Cambridge, MA (US);
Hitoshi Ban, Osaka, JP;
Yukihiro Nishio, Osaka, JP;
Masashi Goto, Osaka, JP;
Toshio Nishihara, Osaka, JP;
Yosuke Takanashi, Osaka, JP;
SUMITOMO DAINIPPON PHARMA CO., LTD., Osaka-shi, JP;
INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC., Suita-shi, JP;
Abstract
A compound represented by the formula (1): wherein Xand Yare each a single bond and the like, cancer antigen peptide A is an MHC class I-restricted WT1 peptide consisting of 7-30 amino acid residues, Ris a hydrogen atom, a group represented by the formula (2): wherein Xand Yare each a single bond and the like, cancer antigen peptide B has a sequence different from that of the cancer antigen peptide A, and is an MHC class I-restricted WT1 peptide consisting of 7-30 amino acid residues, or cancer antigen peptide C, and cancer antigen peptide C has a sequence different from that of the cancer antigen peptide A, and is an MHC class I-restricted WT1 peptide or an MHC class II-restricted WT1 peptide, consisting of 7-30 amino acid residues containing one cysteine residue, or a salt thereof, and the like.